Rakha Emad A, Quinn Cecily
Pathology Department, School of Medicine, The University of Nottingham, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Department of Pathology, Hamad Medical Corporation, Doha, Qatar.
Histopathology. 2025 Mar;86(4):497-513. doi: 10.1111/his.15310. Epub 2024 Aug 29.
Malignant papillary lesions, and in particular, encapsulated papillary carcinoma (EPC) of the breast, continue to present diagnostic challenges for the practising pathologist. In addition to the relative rarity of these lesions, the lack of evidence-based diagnostic criteria, differences in the biological characteristics, and the clinical behaviour of in situ and invasive forms, variable use of immunohistochemical markers, and overlap with other tumour types including high-grade circumscribed forms of invasive breast carcinomas has resulted in diagnostic discordance with potentially significant clinical and management implications. Pathologists should be familiar with the range of morphology observed in malignant papillary tumours, EPC, and EPC-like tumours and the existence of tumours with overlapping features. In this review we summarize the common diagnostic pitfalls in malignant papillary tumours and provide an approach to the diagnostic evaluation and categorisation of these enigmatic entities.
恶性乳头状病变,尤其是乳腺的包膜内乳头状癌(EPC),仍然给执业病理学家带来诊断挑战。除了这些病变相对罕见外,缺乏循证诊断标准、生物学特征差异、原位和浸润性形式的临床行为、免疫组化标志物的使用差异,以及与其他肿瘤类型(包括高级别局限性浸润性乳腺癌)的重叠,导致诊断不一致,可能产生重大的临床和管理影响。病理学家应熟悉在恶性乳头状肿瘤、EPC和EPC样肿瘤中观察到的形态学范围,以及具有重叠特征的肿瘤的存在。在本综述中,我们总结了恶性乳头状肿瘤常见的诊断陷阱,并提供了一种对这些难以捉摸的实体进行诊断评估和分类的方法。